The benchmark indices snapped three-session long gaining streak to end flat on Tuesday tracking negative trend seen in Asian and European markets after North Korea fired a missile that landed in Japanese waters, deepening concerns over the isolated nation's nuclear capabilities.
Back home, investors booked profits in recent outperformers such as ITC, although energy firms gained on lower oil prices.
The S&P BSE Sensex ended at 31,209, down 11 points, while the broader Nifty50 was ruling at 9,613, down 1 point.
In the broader market, the S&P BSE Midcap index slipped 0.3%, while the S&P BSE Smallcap index settled little changed.
The breadth, indicating the overall health of the market was slightly positive. On BSE, 1,338 shares rose and 1,320 shares fell. A total of 135 shares were unchanged.
Sectors and stocks
Recent gainers led the declines. Cigarette maker ITC, which hit a record high and drove the markets higher on Monday, was down 1.3%.
The Nifty Auto index was down 0.5% with Hero MotoCorp (down 2%) losing the most on the index. Tata Motors DVR and MRF slid 1% each.
Meanwhile, commercial vehicles maker Ashok Leyland, which hit its highest in a year on Monday, was down 0.6%.
Among gainers, energy stocks led, with Reliance Industries and Bharat Petroleum Corp climbing more than 2% each after oil prices retreated, halting a straight eight-day run of gains on signs that a persistent rise in US crude production is running out of steam.
The Nifty Energy index was up as much as 1.5%, its biggest intraday percentage gain in almost three weeks.
Get real time advice for Intraday Trading Tips , Intraday Market Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , Equity Tips and all Maket Updates From Capitalstars .
Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
0 comments:
Post a Comment